Animal study shows benefit from gene therapy in late-stage eye disease
Corrective gene therapies for an inherited eye disease could allow even patients with later stages of the disease to benefit from intervention.
Corrective gene therapies for an inherited eye disease could allow even patients with later stages of the disease to benefit from intervention.
Sanofi is assessing its network of 102 sites as part of a €1.5bn cost-saving plan but says it will continue to invest in biologics.
Single use
As GE ships the world’s largest ready-made biomanufacturing plant to China, the team involved tells us modular facilities are in demand from southeast Asian governments – and could hold the key to future pandemic treatments.
A scalable purification system using QuickGel technology can improve cell viability, purity and recovery of cells, says developer Quad Technologies.